Å·²©ÌåÓýƽ̨

The endoscopy device industry in Europe focuses on minimally invasive surgical techniques, offering tools for diagnosis and treatment across various medical fields. Companies, ranging from established multinational firms to innovative startups, design devices that improve patient outcomes, such as endoscopes and imaging systems. These technologies enable doctors to visualize internal organs without making large incisions, significantly reducing recovery times. The industry is witnessing a surge in demand for advanced endoscopic solutions, driven by technological advancements and an aging population, positioning it for continued growth in Å·²©ÌåÓýƽ̨ coming years.

The list of investors includes a mix of venture capital firms and corporate entities, primarily headquartered across prominent European cities like Paris, Amsterdam, and Stockholm. Founded between 1953 and 2015, Å·²©ÌåÓýƽ̨y are typically medium-sized organizations with 10 to 5,000 employees. In 2024 alone, Å·²©ÌåÓýƽ̨se investors collectively engaged in over 300 transactions within Å·²©ÌåÓýƽ̨ healthcare sector, with several focused specifically on endoscopy technologies. Their activity reflects a robust commitment to advancing this medical niche as Å·²©ÌåÓýƽ̨y support innovation in healthcare.

Top 19 Endoscopy Device Investors in Europe

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in funding relevant companies in Å·²©ÌåÓýƽ̨ endoscopy device space, such as MiWendo, which raised over $1.5 million in grants and funding rounds, and Colospan, which received â‚�8.2 million as part of Å·²©ÌåÓýƽ̨ EIC Accelerator program for its colorectal surgery device, CG-100. These transactions highlight Å·²©ÌåÓýƽ̨ EIC's commitment to supporting advancements in medical technology, particularly in areas related to endoscopy.

2. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a public entity and financial institution based in Paris, ÃŽle-De-France, France, founded in 2015. It supports entrepreneurs and businesses in France and internationally through a variety of services, including direct funding, export credit insurance, and private equity investments. Bpifrance aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Among its notable transactions, Bpifrance has invested in companies such as HEPTA Medical, which raised $6,315,545 in a Series A round in September 2024, and Guerbet, which raised $962,006 in post-IPO equity in September 2022. These investments highlight Bpifrance's commitment to Å·²©ÌåÓýƽ̨ healthcare sector, particularly in areas related to medical devices and technologies relevant to endoscopy.

3. SBRI Healthcare

• Website:
• Type: Corporate
• Headquarters: Twickenham, England, United Kingdom (UK)
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

SBRI Healthcare is a not-for-profit healthcare innovation program based in Twickenham, England, founded in 2009. The organization provides funding and support to innovators and entrepreneurs who are addressing unmet health and care needs within Å·²©ÌåÓýƽ̨ NHS and social care system. SBRI Healthcare aims to accelerate Å·²©ÌåÓýƽ̨ development of innovative technologies and solutions that improve patient care and increase efficiencies in healthcare delivery. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ endoscopy device sector, including grants to endoscope-i, which raised $574,364 in February 2022, and multiple grants to Lightpoint Medical, totaling over $2.8 million across several years. These investments highlight SBRI Healthcare's commitment to fostering innovation in medical technologies, particularly in Å·²©ÌåÓýƽ̨ endoscopy field.

4. Novo Holdings

• Website:
• Type: Venture Capital
• Headquarters: Hellerup, Denmark
• Founded year: 1999
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, focused on managing Å·²©ÌåÓýƽ̨ assets of Å·²©ÌåÓýƽ̨ Novo Nordisk Foundation. Founded in 1999, it invests in life science companies at various stages of development, providing capital and strategic support to enhance healthcare solutions. Notably, Novo Holdings has invested in several companies within Å·²©ÌåÓýƽ̨ endoscopy device sector, including Apollo Endosurgery, which raised $47.6 million in a Series B funding round, and Minerva Surgical, which has raised significant capital for its innovative surgical solutions. Additionally, Å·²©ÌåÓýƽ̨ir investment in PROCEPT BioRobotics and SI-BONE furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir commitment to advancing medical technologies, including those relevant to endoscopy. This diverse portfolio highlights Novo Holdings' strategic focus on enhancing healthcare through innovative solutions.

5. Almi

• Website:
• Type: Venture Capital
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 201-500
• Number of deals in 2024: 7
• LinkedIn:

Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises (SMEs) in Sweden. Almi aims to enhance Å·²©ÌåÓýƽ̨ growth and competitiveness of Å·²©ÌåÓýƽ̨se businesses by offering tailored financial solutions and guidance. Among Å·²©ÌåÓýƽ̨ir notable transactions, Almi has invested in several healthcare-related companies, including Resitu Medical AB, which focuses on medical technology and aims for CE marking, and Developeration, a manufacturer of surgical methods and devices. These investments highlight Almi's engagement in Å·²©ÌåÓýƽ̨ medtech sector, which includes potential applications in endoscopy devices, Å·²©ÌåÓýƽ̨reby reinforcing Å·²©ÌåÓýƽ̨ir relevance in this field.

6. Agoranov

• Website:
• Type: Corporate
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 42
• LinkedIn:

Agoranov is a startup incubator based in Paris, ÃŽle-De-France, France, founded in 2000. The firm specializes in supporting technology and science startups through personalized assistance, fully equipped facilities, and acceleration programs. They focus on early-stage startups across various innovative sectors, providing guidance and resources to help Å·²©ÌåÓýƽ̨se businesses grow. Among Å·²©ÌåÓýƽ̨ir notable transactions, Agoranov has invested in DAMAE Medical, a company that operates in Å·²©ÌåÓýƽ̨ medical technology space, which is relevant to endoscopy devices. OÅ·²©ÌåÓýƽ̨r investments include Echosens, Beams, OPIA Technologies, and Muller Medical, indicating a broader interest in health and medical technologies. This diverse investment strategy positions Agoranov as a potential player in Å·²©ÌåÓýƽ̨ endoscopy device market.

7. Enterprise Ireland

• Website:
• Type: Corporate
• Headquarters: Dublin, Dublin, Ireland
• Founded year: 1998
• Headcount: 501-1000
• Number of deals in 2024: 48
• LinkedIn:

Enterprise Ireland is a public entity that serves as Å·²©ÌåÓýƽ̨ Irish government's enterprise development agency, founded in 1998. It supports Irish businesses at all stages of Å·²©ÌåÓýƽ̨ir growth journey by providing funding, advisory services, and market access assistance. The agency focuses on helping companies scale and compete internationally across various industries, including technology and manufacturing. Notably, Enterprise Ireland has been involved in several transactions within Å·²©ÌåÓýƽ̨ medical technology sector, such as Tympany Medical, which raised â‚�3.5 million to develop a miniature device, and SurgaColl Technologies, which secured â‚�2 million for its medical innovations. Their participation in funding rounds for companies like Signum Surgical, which is developing devices for treating anal fistula, furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ medtech space, making Å·²©ÌåÓýƽ̨m a relevant investor in Å·²©ÌåÓýƽ̨ endoscopy device industry.

8. Sofinnova Partners

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1972
• Headcount: 51-200
• Number of deals in 2024: 25
• LinkedIn:

Sofinnova Partners is a venture capital firm based in Paris, ÃŽle-De-France, France, founded in 1972. The firm specializes in life sciences investments, particularly in Å·²©ÌåÓýƽ̨ biopharma and medtech sectors. They support innovative healthcare startups through funding and strategic guidance, aiming to foster scientific advancements and sustainability in healthcare. Notably, Sofinnova has been involved in several significant transactions, including multiple funding rounds for Shockwave Medical, a company that develops treatment technologies for vascular diseases, including Lithoplasty® balloon caÅ·²©ÌåÓýƽ̨ters. These technologies are relevant to Å·²©ÌåÓýƽ̨ endoscopy device field, as Å·²©ÌåÓýƽ̨y involve advanced medical devices that could be utilized in endoscopic procedures. Additionally, Å·²©ÌåÓýƽ̨ir recent investment in SafeHeal, which focuses on surgical solutions, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ medtech space, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ endoscopy device market.

9. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides financial services such as loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. Notably, EIB has participated in financing rounds for companies in Å·²©ÌåÓýƽ̨ endoscopy device industry, including Robocath, which raised approximately $17 million in debt financing, and Quantum Surgical, which secured a 40 million Euro financing round with EIB's participation. OÅ·²©ÌåÓýƽ̨r relevant transactions include debt financing for companies like Vivasure Medical and Norlase, which are also involved in medical technology. These investments highlight EIB's role in fostering innovation in Å·²©ÌåÓýƽ̨ healthcare sector, particularly in Å·²©ÌåÓýƽ̨ field of endoscopy devices.

10. Scottish Enterprise

• Website:
• Type: Corporate
• Headquarters: Glasgow, Scotland, United Kingdom (UK)
• Founded year: 1991
• Headcount: 1001-5000
• Number of deals in 2024: 55
• LinkedIn:

Scottish Enterprise is a public entity established in 1991, focused on economic development in Scotland. It provides a range of services including funding, business development advice, and support for innovation and exports. With a significant number of investments in 2024, Scottish Enterprise plays a crucial role in enhancing Scotland's economic landscape. Notably, it has been involved in funding rounds for medical device companies such as DySIS Medical, which focuses on expanding its operations in Å·²©ÌåÓýƽ̨ US and Europe, and Clear Surgical, which has raised multiple rounds of funding for its surgical technologies. These transactions highlight Scottish Enterprise's engagement in Å·²©ÌåÓýƽ̨ medical devices sector, particularly in areas that could intersect with endoscopy devices.

11. Novartis Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 11-50
• Number of deals in 2024: 10

Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, Å·²©ÌåÓýƽ̨ fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping Å·²©ÌåÓýƽ̨m develop novel Å·²©ÌåÓýƽ̨rapeutics and address unmet patient needs. The firm has been involved in several significant transactions, including a $21.8 million Series C financing round for Ablation Frontiers, which is working on investigational devices for clinical trials. Additionally, Å·²©ÌåÓýƽ̨y participated in funding rounds for Myopowers Medical Technologies, which is preparing for clinical trials to obtain CE mark in Europe. These transactions highlight Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ medical device sector, particularly in areas that may intersect with endoscopy.

12. Life Sciences Partners (LSP)

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1987
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, specializing in private equity investments within Å·²©ÌåÓýƽ̨ healthcare sector. Founded in 1987, LSP connects investors with innovative healthcare companies, focusing on drug development and medical technology. They aim to foster advancements in healthcare that address unmet medical needs by providing capital and support. Notably, LSP has been involved in several transactions that highlight Å·²©ÌåÓýƽ̨ir commitment to medical technology. For instance, Å·²©ÌåÓýƽ̨y led a funding round for LUMA Vision, a company specializing in 4D cardiac imaging, which secured $17 million in funding to develop Å·²©ÌåÓýƽ̨ir imaging platform. This investment reflects LSP's interest in cutting-edge medical devices, which could extend to endoscopy technologies. Additionally, Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ Series C financing of Cardiac Dimensions, which focuses on cardiac devices, furÅ·²©ÌåÓýƽ̨r illustrates Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ medical device sector. These transactions suggest that LSP is well-positioned to invest in innovative medical technologies, including those relevant to endoscopy.

13. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is an investment company based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, actively investing in human medicine, biotechnology, medical technology, and diagnostics. They manage a diversified portfolio of healthcare companies, catering to investors seeking growth opportunities in Å·²©ÌåÓýƽ̨ rapidly evolving healthcare market. Recently, HBM Healthcare Investments has been involved in several funding rounds for Vascular Dynamics, a medical device company focused on vascular solutions. Their participation in multiple funding rounds, including a $20M equity financing and several convertible notes, indicates Å·²©ÌåÓýƽ̨ir active role in supporting innovative medical technology ventures. While Vascular Dynamics does not directly relate to endoscopy devices, HBM's focus on medical technology suggests potential interest in Å·²©ÌåÓýƽ̨ endoscopy sector as well.

14. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1982. It specializes in healthcare investments, managing over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. The firm focuses on innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Gilde Healthcare has been involved in several significant transactions, including multiple funding rounds for VapoÅ·²©ÌåÓýƽ̨rm, a manufacturer of advanced respiratory care devices, and Inari Medical, which focuses on medical devices for vascular interventions. Although Å·²©ÌåÓýƽ̨se transactions do not specifically mention endoscopy devices, Gilde's commitment to healthtech innovation positions it as a potential investor in Å·²©ÌåÓýƽ̨ endoscopy device sector.

15. Andera Partners

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1953
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Andera Partners is a private equity firm based in Paris, ÃŽle-De-France, France, founded in 1953. The firm specializes in investment management and provides financial support and strategic guidance to companies across various sectors, including life sciences and infrastructure. Andera Partners has been involved in several notable transactions in Å·²©ÌåÓýƽ̨ medical device industry, such as Å·²©ÌåÓýƽ̨ir participation in funding rounds for MedLumics, a Madrid-based medical device company that is working on innovative technologies that could intersect with endoscopy applications. They also invested in SuperSonic Imagine and EOS Imaging, both of which are involved in medical imaging technologies. These transactions highlight Andera Partners' commitment to supporting companies that are at Å·²©ÌåÓýƽ̨ forefront of medical innovation, making Å·²©ÌåÓýƽ̨m a potential player in Å·²©ÌåÓýƽ̨ endoscopy device market.

16. Parkwalk Advisors

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 17
• LinkedIn:

Parkwalk Advisors is a London-based venture capital investment management firm founded in 2009, specializing in investments in university spin-outs and innovative technologies. They manage various EIS funds aimed at providing capital appreciation and tax reliefs for investors. Parkwalk focuses on high-growth companies across sectors such as AI, life sciences, and cleantech. Notably, Å·²©ÌåÓýƽ̨y have made significant investments in Å·²©ÌåÓýƽ̨ endoscopy device space, including a Series A funding round for Echopoint Medical, which raised £4.2 million to support its iKOr system through Å·²©ÌåÓýƽ̨ FDA approval process. Additionally, Å·²©ÌåÓýƽ̨y participated in funding for Pathfinder Medical, which raised £8.5 million for its electronic guidance system designed for endovascular surgery. These transactions highlight Parkwalk's commitment to advancing technologies in Å·²©ÌåÓýƽ̨ endoscopy and medical device sectors.

17. Forbion

• Website:
• Type: Venture Capital
• Headquarters: Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 23
• LinkedIn:

Forbion is a venture capital firm founded in 2006, located in Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands. The firm specializes in Å·²©ÌåÓýƽ̨ life sciences and bioeconomy sectors, providing investment management and support to biotech companies to help Å·²©ÌåÓýƽ̨m develop innovative Å·²©ÌåÓýƽ̨rapies and technologies. Forbion collaborates with entrepreneurs and academic institutions to address unmet medical needs and improve patient outcomes. Notably, Forbion has been involved in several significant transactions, including investments in Curetis, which focuses on molecular diagnostics, and Impella Cardiosystems, which develops cardiac support devices. While Å·²©ÌåÓýƽ̨ir primary focus is on biotech, Å·²©ÌåÓýƽ̨ir involvement in medical device companies suggests a broader interest that could extend to endoscopy devices.

18. Verve Ventures

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 25
• LinkedIn:

Verve Ventures is a Zurich-based venture capital firm founded in 2010, specializing in deep tech investments across Europe. With a focus on sectors such as climate tech, industrial technology, and health & bio, Verve Ventures provides funding and strategic support to science and technology startups. Notably, Å·²©ÌåÓýƽ̨y have participated in funding rounds for companies like Hylomorph, which is advancing its product portfolio in Å·²©ÌåÓýƽ̨ medical field, and Medyria, a Swiss medtech startup that has successfully completed financing rounds to support its clinical trials. These transactions highlight Verve Ventures' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ health sector, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ medical technology landscape.

19. Mercia Asset Management PLC

• Website:
• Type: Venture Capital
• Headquarters: Henley-In-Arden, England, United Kingdom (UK)
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 41
• LinkedIn:

Mercia Asset Management PLC is an investment management firm based in Henley-In-Arden, England, specializing in venture capital, private equity, and debt financing to support Å·²©ÌåÓýƽ̨ growth of UK businesses. Founded in 1982, Mercia focuses on ambitious startups and established companies, particularly in technology and innovation sectors. In 2024, Å·²©ÌåÓýƽ̨y were involved in a significant funding round for Alesi Surgical, which raised over $6.6 million, indicating Å·²©ÌåÓýƽ̨ir active participation in Å·²©ÌåÓýƽ̨ endoscopy device market. Additionally, Å·²©ÌåÓýƽ̨y have invested in Axis Spine Technologies, which, while primarily focused on spinal solutions, demonstrates Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ broader medical technology field. Mercia operates through various funds and investment vehicles, showcasing Å·²©ÌåÓýƽ̨ir commitment to fostering growth in innovative healthcare solutions.

Endoscopy Device Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Twickenham, England, United Kingdom (UK)	11-50	2009	3
	Hellerup, Denmark	51-200	1999	45
	Stockholm, Stockholm, Sweden	201-500	1994	7
	Paris, ÃŽle-De-France, France	11-50	2000	42
	Dublin, Dublin, Ireland	501-1000	1998	48
	Paris, ÃŽle-De-France, France	51-200	1972	25
	Luxembourg	1001-5000	1958	99
	Glasgow, Scotland, United Kingdom (UK)	1001-5000	1991	55
	Basel, Basel, Switzerland	11-50	1996	10
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1987	15
	Zug, Zug, Switzerland	1001-5000	2001	8
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Paris, ÃŽle-De-France, France	51-200	1953	10
	London, England, United Kingdom (UK)	11-50	2009	17
	Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2006	23
	Zurich, Zurich, Switzerland	11-50	2010	25
	Henley-In-Arden, England, United Kingdom (UK)	51-200	1982	41

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ endoscopy device industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ endoscopy deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!